Cancer cell targeting with mouse TERT-specific group I intron of Tetrahymena thermophila

Journal of Microbiology and Biotechnology

Volumn 19, Issue 9, 2009, Pages 1070-1076

  Ban, Guyee ^a   Song, Min Sun ^a   Lee, Seong Wook ^a  

^a Dankook University   (South Korea)

Author keywords

Cancer; Gene therapy; Group I intron; mTERT; RNA replacement; Trans splicing ribozyme

Indexed keywords

RIBOZYME; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG TARGETING; EMBRYO; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRON; NONHUMAN; SUICIDE GENE; TETRAHYMENA THERMOPHILA; TRANS SPLICING; TRANSGENE;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; EXONS; FIBROBLASTS; GENES, TRANSGENIC, SUICIDE; HUMANS; INTRONS; LIVER NEOPLASMS; LUNG; MICE; TELOMERASE; TETRAHYMENA THERMOPHILA;

ANIMALIA; SIMPLEXVIRUS; TETRAHYMENA; TETRAHYMENA THERMOPHILA;

EID: 70849125116     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.0812.692     Document Type: Article

References (35)

1. Bodnar, A. G., M. Ouellette, M. Frolkis, S. E. Holt, C. P. Chiu, G. B. Morin, et al. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352. (Pubitemid 28063364)
2. Byun, J., N. Lan, M. Long, and B. A. Sullenger. 2003. Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes. RNA 9: 1254-1263. (Pubitemid 37151679)
3. Fiammengo, R. and A. Jaschke. 2005. Nucleic acid enzymes. Curr. Opin. Biotechnol. 16: 614-621.
4. Forsyth, N. R., W. E. Wright, and J. W. Shay. 2002. Telomerase and differentiation in multicellular organisms: Turn it off, turn it on, and turn it off again. Differentiation 69: 188-197.
5. Greenberg, R. A., R. C. Allsopp, L. Chin, G. B. Morin, and R. A. DePinho. 1998. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16: 1723-1730. (Pubitemid 28175053)
6. Hong, S. H., J. S. Jeong, Y. J. Lee, H. I. Jung, K. S. Cho, C. M. Kim, et al. 2008. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells. Mol. Ther. 16: 74-80.
7. Jeong, J. S., S. W, Lee, S. H. Hong, Y. J. Lee, H. I. Jung, K. S. Cho, et al. 2008. Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model. Clin. Cancer Res. 14: 281-290.
8. Jones, J. T., S. W. Lee, and B. A. Sullenger. 1996. Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nature Med. 2: 643-648.
9. Kohler, U., B. G. Ayre, H. M. Goodman, and J. Haseloff. 1999. Trans-splicing ribozymes for targeted gene delivery. J. Mol. Biol. 185: 1935-1950.
10. Kim, A., G. Ban, M. S. Song, C. D. Bae, J. Park, and S. W. Lee. 2007. Selective regression of cells expressing mouse cytoskeleton-associated protein 2 transcript by trans-splicing ribozyme. Oligonucleotides 17: 95-103. (Pubitemid 46651431)
11. Kim, N. W., M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. Ho, et al. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
12. Kwon, B. S., H. S. Jung, M. S. Song, K. S. Cho, S. C. Kim, K. Kimm, J. S. Jeong, I. H. Kim, and S. W. Lee. 2005. Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript. Mol. Ther. 12: 824-834.
13. Lan, N., R. P. Howrey, S. W. Lee, C. A. Smith, and B. A. Sullenger. 1998. Ribozyme-mediated repair of sickle β-globin mRNAs in erythrocyte precursors. Science 280: 1593-1596. (Pubitemid 28277702)
14. Lan, N., B. L. Rooney, S. W. Lee, R. P. Howrey, C. A. Smith, and B. A. Sullenger. 2000. Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA. Mol. Ther. 2: 245-255.
15. Lee, G. P. 2007. A minor transactivation effect of GATA-3 on its target sites in the extrachromosomal status. J. Microbiol. Biotechnol. 17: 2056-2060.
16. Lee, H. Y., N. Naha, J. H. Kim, M. J. Jo, K. S. Mi, H. H. Seong, D. H. Shin, and M. O. Kim. 2008. Age- and area-dependent distinct effects of ethanol on Bax and Bcl-2 expression in prenatal rat brain. J. Microbiol. Biotechnol. 18: 1590-1598.
17. Long, M. B., J. P. Jones 3rd, B. A. Sullenger, and J. Byun. 2003. Ribozyme-mediated revision of RNA and DNA. J. Clin. Invest. 112: 312-318.
18. Masutomi, K. and W. C. Hahn. 2003. Telomerase and tumorigenesis. Cancer Lett. 194: 163-172.
19. Matthews, T. and R. Boehme. 1988. Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 10: S490-S494.
20. Mesnil, M., C. Piccoli, G. Tiraby, K. Willecke, and H. Yamasaki. 1996. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc. Natl. Acad. Sci. U.S.A. 93: 1831-1835.
21. Meyerson, M., C. M. Counter, E. N. Eaton, L. W. Ellisen, P. Steiner, S. D. Caddle, et al. 1997. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795. (Pubitemid 27357969)
22. Newbold, R. F. 1997. Genetic control of telomerase and replicative senescence in human and rodent cells. Ciba Found. Symp. 211:177-189.
23. Phylactou, L. A., C. Darrah, and M. J. Wood. 1998. Ribozyme-mediated trans-splicing of a trinucleotide repeat. Nat. Genet. 18: 378-381.
24. Ryu, K. J., J. H. Kim, and S. W. Lee. 2003. Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted transsplicing. Mol. Ther. 7: 386-395.
25. Shay, J. W. and S. Bacchetti. 1997. A survey of telomerase activity in human cancer. Eur. J. Cancer 33: 787-791. (Pubitemid 27239490)
26. Shay, J. W. and W. E. Wright. 2002. Telomerase: A target for cancer therapeutics. Cancer Cell 2: 257-265.
27. Shin, K. S., B. A. Sullenger, and S. W. Lee. 2004. Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA. Mol. Ther. 10: 365-372.
28. Shi, H. Y., W. Zhang, R. Liang, S. Abraham, F. S. Kittrell, D. Medina, and M. Zhang. 2001. Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res. 61: 6945-6951.
29. Smith, L. L., H. A. Coller, and J. M. Roberts. 2003. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 5: 474-479.
30. Song, M. S. and S. W. Lee. 2006. Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted transsplicing ribozyme. FEBS Lett. 580: 5033-5043.
31. Song, M. S. and S. W. Lee. 2007. An RNA mapping strategy to identify ribozyme-accessible sites on the catalytic subunit of mouse telomerase. Genom. Inform. 5: 32-35.
32. Song, M. S., J. S. Jeong, G. Ban, J. H. Lee, Y. S. Won, K. S. Cho, I. H. Kim, and S. W. Lee. 2008. Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo. Cancer Gene Ther. 16: 113-125.
33. Sullenger, B. A. and T. R. Cech. 1994. Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature 317: 619-622.
34. Sullenger, B. A. 1995. Revising messages traveling along the cellular information highway. Chem. Biol. 2: 249-253.
35. Weitzman, J. B. and M. Yaniv. 1999. Rebuilding the road to cancer. Nature 400: 401-402.